Tag: pharmaceuticals
-
Carb-X Funding Nanoscale Sponge to Treat Sepsis
A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment.
-
Covid-19 Vaccine Challenge Trial Underway
Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines.
-
Myeloma Drug Shown to Treat Covid-19 Patients
Results from an early clinical trial show a drug designed to treat multiple myeloma also reduces viral loads and hospital stays of patients with Covid-19 infections.
-
ALS Drug Shown to Extend Patient Survival
Results of a clinical trial show a drug to treat amyotrophic lateral sclerosis, or ALS, extends patients’ survival by several months and slows decline of their functions.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-
Cancer Center, Biotech Partner on Off-the-Shelf T-Cells
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells.
-
Gene Therapy Delivery Tech Licensed in $1.8B Deal
A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche.
-
NIH Trial Testing Current Drugs to Treat Covid-19
A clinical trial is planned to assess two drugs designed for other medical conditions as treatments for Covid-19 infections.
-
Start-Up Gains Access to Vaccine Nasal Spray Technology
A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston.
-
DoD Funding Mobile Vaccine/Therapy Manufacturing Lab
The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand.